CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 116 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $181,137 | +10.4% | 6,582 | +36.1% | 0.00% | 0.0% |
| Q2 2023 | $164,085 | -5.7% | 4,836 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $173,999 | +3.2% | 4,836 | +27.8% | 0.00% | 0.0% |
| Q4 2022 | $168,608 | +59.1% | 3,783 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $106,000 | +3.9% | 3,783 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $102,000 | -46.6% | 3,783 | -32.6% | 0.00% | 0.0% |
| Q1 2022 | $191,000 | +19.4% | 5,610 | +35.1% | 0.00% | 0.0% |
| Q4 2021 | $160,000 | -28.6% | 4,151 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $224,000 | +61.2% | 4,151 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $139,000 | +172.5% | 4,151 | +67.5% | 0.00% | – |
| Q1 2021 | $51,000 | – | 2,478 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,605,390 | $71,552,232 | 10.98% |
| Octagon Capital Advisors LP | 761,398 | $33,935,509 | 5.28% |
| TSP Capital Management Group, LLC | 269,895 | $12,029,225 | 4.50% |
| Redmile Group, LLC | 1,977,451 | $88,134,991 | 3.60% |
| COMMODORE CAPITAL LP | 495,823 | $22,099 | 3.33% |
| Tri Locum Partners LP | 176,109 | $7,849,000 | 3.18% |
| ACUTA CAPITAL PARTNERS, LLC | 115,000 | $5,125,550 | 3.15% |
| Ikarian Capital, LLC | 267,476 | $11,921,406 | 2.88% |
| RTW INVESTMENTS, LP | 3,084,215 | $137,463,463 | 2.81% |
| Eversept Partners, LP | 558,774 | $24,904,557 | 2.18% |